BIO-TECHNE Corp — Director's Dealing 2016

Feb 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-02-05

Reporting Person: LUCAS ROGER C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-05	Common Stock	M	5000.00	$70.35	Acquired	9515.00	Direct
2016-02-05	Common Stock	S	5000.00	$83.68	Disposed	4515.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-05	Stock Options (Right to Buy)	$70.35	M	5000.00	Disposed	2021-10-26	Common Stock (5000.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$91.78	2024-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Options (Right to Buy)	$87.39	2023-10-30	Common Stock (4000.00)	4000.00	Direct
Stock Options (Right to Buy)	$87.34	2025-10-28	Common Stock (4260.00)	4260.00	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.11 to $84.06 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.